Chai Discovery · 1 week ago
Alliances Manager
Chai Discovery builds frontier AI models to revolutionize drug discovery. They are seeking an Alliance Manager to ensure healthy biopharma partnerships, manage client-facing projects, and collaborate with field scientists to deliver successful outcomes.
Artificial Intelligence (AI)Health CareLife Science
Responsibilities
Own relationship health across strategic partners: keep metrics green, detect risk signals early, drive resolution
Manage client-facing projects and collaborations end-to-end
Partner with field scientists to ensure timely and successful delivery against all commitments
Escalate and translate feedback from partners back to the rest of the company
Qualification
Required
Proven experience in alliance management, strategic partnerships, customer success, or similar roles in biopharma/biotech
Operationally oriented: you like to build systems, hold timelines, and keep everyone on the same page—without ever dropping balls
Strong relationship builder with high EQ, executive presence, and excellent communication skills
Sufficient scientific fluency to understand the work and support scientific counterparts
Thrive in lean, fast-moving environments
Benefits
Frontier technology: work on the technologies that promises to fundamentally change how new therapeutics are created.
World-class people: work with world-renowned leaders in the AI x Biology ecosystem.
Velocity and ownership: we move incredibly fast and liberally distribute ownership, which means continuous learning and career growth opportunities are guaranteed.
Strong culture and mission: we foster a supportive culture that is mission-driven and high-energy.
Highly competitive compensation: we attract the best talent and compensate them accordingly.
Company
Chai Discovery
Chai Discovery develops artificial intelligence models that predict and reprogram biochemical molecule interactions.
Funding
Current Stage
Growth StageTotal Funding
$231MKey Investors
Amazon Web ServicesMenlo Ventures
2025-12-15Series B· $130M
2025-10-07Non Equity Assistance· $1M
2025-08-06Series A· $70M
Recent News
Genetic Engineering News
2026-01-16
2026-01-16
Company data provided by crunchbase